(Q33527568)

27 July 2017

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group (English)

1 reference

27 July 2017

phase I clinical trial

0 references

0 references

1 reference

Debbie S Gipson

6

0 references

Howard Trachtman

object named as

Howard Trachtman

11

0 references

Virginia J Savin

7

object named as

Virginia Savin

1 reference

27 July 2017

Alexandra Peyser

1

1 reference

27 July 2017

Nathaniel Machardy

2

1 reference

27 July 2017

Freya Tarapore

3

1 reference

27 July 2017

Jacqueline Machardy

4

1 reference

27 July 2017

Leslie Powell

5

1 reference

27 July 2017

Cynthia Pan

8

1 reference

27 July 2017

Theresa Kump

9

1 reference

27 July 2017

Suzanne Vento

10

1 reference

27 July 2017

29 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

11

1 reference

27 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-11-2

27 July 2017

0 references

cites work

Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Glomerular filtration rate measurement and prediction equations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Redefining the role of thiazolidinediones in the management of type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

New equations to estimate GFR in children with CKD

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

10-year follow-up of intensive glucose control in type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Surrogate end points for clinical trials of kidney disease progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Genetics of focal segmental glomerulosclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2823728

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2369-11-2

UKPDS and the legacy effect.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2369-11-2

Primary glomerulonephritis: an update on renal survival and determinants of progression

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2369-11-2

Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis

21 January 2018

1 reference

12 December 2020

Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment

1 reference

12 December 2020

Focal segmental glomerulosclerosis in adult African Americans

1 reference

12 December 2020

Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-11-2

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-11-2

release_fdp4oyh2afaorowzce5l5ge4pe

9 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fdp4oyh2afaorowzce5l5ge4pe

24 November 2022

mapped directly with Wikidata item

PMCID

2823728

1 reference

27 July 2017

1 reference